BellaSeno

About

BellaSeno is a clinical-stage medical device company based in Leipzig, Germany, with a subsidiary in Brisbane, Australia. Founded in 2015, the company specializes in fully resorbable 3D-printed implants for regenerative medicine, focusing on soft tissue reconstruction, bone defects, and chest wall deformities. BellaSeno utilizes a proprietary additive manufacturing platform to create patient-specific scaffolds from clinically validated polymers, supporting natural tissue growth while eliminating the risks associated with permanent implants. The company develops products through clinical studies and partners with medtech companies for co-development and commercialization. BellaSeno's product offerings include breast scaffolds for reconstruction and augmentation, custom-made pectus scaffolds for chest wall defects, and bone scaffolds designed for complex bone defects. All products are designed to integrate with the body’s healing processes without using biologics or stem cells. BellaSeno is ISO 13485 certified and holds multiple patents related to its innovative technologies.